Investigational new drugThyroid Analog
Compound 61576
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061576
Risk Class
MODERATE
Last Audit
Apr 18, 2108
Research Abstract
Thyroid Analog candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61576 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061576 with updates logged 2108-04-18.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61576Thyroid Analog Program 61576
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061576
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61576